BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//American Liver Foundation - ECPv6.13.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:American Liver Foundation
X-ORIGINAL-URL:https://liverfoundation.org
X-WR-CALDESC:Events for American Liver Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240301T000000
DTEND;TZID=America/New_York:20250329T235959
DTSTAMP:20260420T175657
CREATED:20240805T211801Z
LAST-MODIFIED:20250327T163642Z
UID:10001298-1709251200-1743292799@liverfoundation.org
SUMMARY:Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma (GEA)
DESCRIPTION:We've collaborated with Medscape Oncology Global and Hope for Stomach Cancer to present a CME opportunity for health care professionals seeking to better understand established and emerging data related to HER2-targeted therapies in GEA. This on-demand course is available for continuing education credit until 3/29/25. \nUpon completion of this activity\, participants will: \n\nHave increased knowledge regarding the\n\nBiological rationale for using bispecific antibodies to target HER2 in GEA\n\n\nHave greater competence related to\n\nSelecting the most appropriate anti-HER2 therapy for a patient with HER2-positive GEA\nManaging adverse events associated with anti-HER2 therapies for patients with HER2-positive GEA\n\n\nDemonstrate greater confidence in their ability to\n\nCollaborate with the patient when developing a treatment plan for their HER2-positive GEA\n\n\n\nLearn more and register for this course: https://liver.fyi/HER2GEA \n 
URL:https://liver.fyi/HER2GEA#new_tab
LOCATION:On-Demand
CATEGORIES:Programs
ATTACH;FMTTYPE=image/png:https://liverfoundation.org/wp-content/uploads/2024/08/Fact-Sheet-What-Does-Your-Liver-Do.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241211T190000
DTEND;TZID=America/New_York:20241211T200000
DTSTAMP:20260420T175657
CREATED:20241104T130923Z
LAST-MODIFIED:20241104T133305Z
UID:10001164-1733943600-1733947200@liverfoundation.org
SUMMARY:2024 Year End Advocacy Briefing
DESCRIPTION:Join us for this one-hour live virtual advocacy briefing. We will provide updates around current priorities\, review accomplishments from the past year\, and provide a preview of 2025. Speakers include: \n\n\n\n\nLorraine Stiehl\, CEO\, American Liver Foundation\n\n\n\nBobby Clark\, Pyxis Partners\n\n\n\nSusan Avallone\, ALF Advocacy Ambassador\n\n\n\nWilliam Houston\, ALF Advocacy Ambassador\n\n\n\n\n\n\n\n\nEvent Date: December 11th\, 2024Event Time: 7:00 PM EST Zoom Meeting Link: Please register below to receive the Zoom Link.
URL:https://liverfoundation.org/events/2024-year-end-advocacy-briefing/
LOCATION:Virtual
CATEGORIES:Programs
ATTACH;FMTTYPE=image/jpeg:https://liverfoundation.org/wp-content/uploads/2022/08/ALF-Brand-Refresh-1280x720-1.jpg
END:VEVENT
END:VCALENDAR